Bieber, Frederick, Robert, PHD

Hemophilia is an inherited bleeding disorder in which the blood does not clot normally because of a missing or dysfunctional clotting protein. Clotting proteins, also called clotting factors, work with other blood components such as platelets, von Willebrand factor, and other proteins to form a blood clot. When any of these components is absent or low, increased bleeding can result. If clotting factor VIII (8) or factor IX (9) are affected, this bleeding disorder is called hemophilia.

Harvard-Partners Center for Genetics is a collaborative endeavor within the Mass General Brigham system dedicated to advancing healthcare innovation, patient care, and research in genetic and personalized medicine. The organization encompasses various facilities and services, providing comprehensive healthcare options like primary care, virtual care, and specialized treatment options across its integrated network of hospitals. Focused on cutting-edge research, the Center emphasizes collaboration with innovators and researchers to foster breakthroughs in areas such as artificial intelligence, gene and cell therapy, and population health. Their commitment also extends to education and workforce development, putting a premium on quality and equitable healthcare delivery for diverse communities. Generated from the website